NDC11 73614020403
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 73614-0204-03 | 73614-0204 |
| 73614-0204-3 | 73614-0204 |
| 73614-204-03 | 73614-204 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Hydrochloride | CLINDAMYCIN HYDROCHLORIDE | Brisk Pharmaceuticals | 2de041be-1d36-ee95-e063-6294a90a2091 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | 73614-204-03 73614-204 73614020403 |
| ClindaCare | CLINDAMYCIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2df8a89c-38df-c63b-e063-6394a90aaa36 | 2025-02-10 | 73614-204-03 73614020403 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.